Companies: 10,795·Total market cap: $144.5T
DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc.

DMACNASDAQHealthcare● Active
$5.71
+$0.07(+1.24%)
Market Cap$307673643
P/E Ratio
52W High$10.4195
52W Low$3.475
Overview

DiaMedica Therapeutics Inc. (DMAC) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · DMAC · as of Mar 30, 2026

Latest filing snapshot

35
+7+25.00%vs prior year

DiaMedica Therapeutics Inc. (DMAC) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
35
Change (1Y)
+7
Growth % (1Y)
+25.00%
Revenue / Employee
Net Income / Employee
$-936.2K
Market Cap
$310M

DMAC Employee Count

2018 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-3035+7+25.00%
2025-03-1728+9+47.37%
2024-03-1919+3+18.75%
2023-03-2816+1+6.67%
2022-03-1415+4+36.36%
2021-03-1011+3+37.50%
2020-03-238-1-11.11%
2019-03-199

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Alpha Tau Medical Ltd.
DRTS
Alpha Tau Medical Ltd.
125
#2
Annexon, Inc.
ANNX
Annexon, Inc.
106
#3
DBV Technologies S.A.
DBVT
DBV Technologies S.A.
106
#4
Altimmune, Inc.
ALT
Altimmune, Inc.
59
#5
Design Therapeutics, Inc.
DSGN
Design Therapeutics, Inc.
56
#6
enGene Holdings Inc.
ENGN
enGene Holdings Inc.
56
#7
DiaMedica Therapeutics Inc.
DMAC
DiaMedica Therapeutics Inc.YOU
35
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · DMAC peer comparison

About DMAC employees

DMAC Employees · Headcount

DiaMedica Therapeutics Inc. (DMAC) employee data is sourced from the annual SEC 10-K filing. As of 2025, DiaMedica Therapeutics Inc. had 35 full-time employees globally. Full-time employees only. Global consolidated headcount.

DiaMedica Therapeutics Inc.'s workforce increased by 7 (25.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Frequently Asked Questions

DMAC Employees · 5 questions

As of the latest SEC 10-K filing (2025), DiaMedica Therapeutics Inc. had 35 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

DiaMedica Therapeutics Inc. employee counthow many employees does DiaMedica Therapeutics Inc. haveDMAC total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-30